Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Management of Safety Information from Clinical Trials
The membership of CIOMS Working Group VI has been expanded to include regulatory, industry and academic representation with experience in the conduct of clinical trials as well as representatives from less developed regions of the world. In this report they introduce proposals for enhancing the collection, analysis, evaluation, reporting and overall management of safety information from clinical trials. They also discusses the importance of sponsors having a systematic approach to managing risk during development, taking into account non-clinical as well as clinical data. The book is primarily aimed at providing guidance to sponsor of clinical trials, in the hope that the proposals will enhance the ability to protect patient well-being and optimize the development and use of new medicines.
CIOMS Guide to Active Vaccine Safety Surveillance
This guide offers a practical step-by-step approach and algorithm to aid immunization professionals and decision-makers in determining the best course of action if additional vaccine safety data is needed. The guide provides a structured process for evaluating whether significant knowledge gaps exist, whether passive safety surveillance is adequate, and if not, methods for and practical aspects of conducting active vaccine safety surveillance. The guide also includes an essential vaccine information source list for evaluating the extent of data resources and several case studies for review. With more vaccine solutions available and opportunities for earlier availability of new vaccine produc...
International Ethical Guidelines for Health-Related Research Involving Humans
"In the new 2016 version of the ethical guidelines, CIOMS provides answers to a number of pressing issues in research ethics. The Council does so by stressing the need for research having scientific and social value, by providing special guidelines for health-related research in low-resource settings, by detailing the provisions for involving vulnerable groups in research and for describing under what conditions biological samples and health-related data can be used for research."--Page 4 de la couverture.
Cioms Guide to Vaccine Safety Communication
The CIOMS Guide to Vaccine Safety Communication provides an overview of strategic communication issues faced by medicines regulators, those responsible for vaccination policies and programs and other stakeholders including: (1) the launch of newly-developed vaccines for the first time to market, (2) the introduction of current or underutilized vaccines into new countries, regions, or populations, and (3) the handling of any new safety issue arising during the life-cycle of a vaccine. The Guide sources from existing guidance documents and compiles recommendations relevant from a regulatory perspective, providing a common ground in a way that has not been achieved otherwise at a global level. It stresses the fundamental importance of regulatory bodies having a system in place with skilled persons who can efficiently run vaccine safety communication in collaboration with stakeholders. It presents information and examples with color-coding for quick access to three levels of guidance and offers a CIOMS template to use to create a Vaccine Safety Communication Plan.
Current Challenges in Pharmacovigilance
In spite of recent progress in the harmonization of terminology and processes affecting work on the clinical safety of medicines consensus is needed on standards for many difficult aspects of day-to-day pharmacovigilance that continue to pose problems for both the pharmaceutical industry and drug regulators. The CIOMS V Working Group has generated proposals for pragmatic approaches to dealing with such issues as: classification and handling of individual safety case reports from a variety of sources (spontaneous consumer reports solicited reports literature the Internet observational studies and secondary data bases disease and other registries regulatory ADR databases and licensor-licensee ...
Evidence Synthesis and Meta-analysis for Drug Safety
At any point in the drug development process, systematic reviews and meta-analysis can provide important information to guide the future path of the development program and any actions that might be needed in the post-marketing setting. This report gives the rationale for why and when a meta-analysis should be considered, all in the context of regulatory decision-making, and the tasks, data collection, and analyses that need to be carried out to inform those decisions. There is increasing demand by decision-makers in health care, the bio-pharmaceutical industry, and society at large to have access to the best available evidence on benefits and risks of medicinal products. The best strategy w...
International Ethical Guidelines for Biomedical Research Involving Human Subjects
The present text is the revised/updated version of the CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects. It consists of 21 guidelines with commentaries. A prefatory section outlines the historical background and the revision process and includes an introduction an account of earlier instruments and guidelines a statement of ethical principles and a preamble. An Appendix lists the items to be included in the research protocol to be submitted for scientific and ethical review and clearance. The Guidelines relate mainly to ethical justification and scientific validity of research; ethical review; informed consent; vulnerability - of individuals groups comm...
Definition and Application of Terms for Vaccine Pharmacovigilance
This report from the Council for International Organizations of Medical Sciences (CIOMS) in collaboration with WHO covers the activities and outputs of the CIOMS/WHO Working Group on Vaccine Pharmacovigilance (2005-2010). This working group brought together experts from both industrialized and emerging countries representing regulatory agencies, vaccine industry, national and international public health bodies including WHO and CIOMS, academia and clinical care, contributing from their different perspectives. The report covers general terms and definitions for vaccine safety and discusses the application of such harmonized tools in vaccine safety surveillance and studies. As well, the report highlights case definitions for adverse events typically reported for vaccines. The report is addressed to those engaged in vaccine safety data collection and evaluation, and will also make a useful reading for others who want to familiarize themselves with vaccine safety terminology.
